Registration opens for AUGS Pelvic Floor Disorders (PFD) Week 2023

Apply to join the 4th cohort of the Urogynecology Clinical Research Educational Scientist Training (UrogynCREST) program – a collaboration between Duke University and AUGS.

In this episode of Speaking of Urology®, Ashley G. Winter, MD, discusses the use of vaginal estrogen.

AUGS presents a collection of recent articles from the Urogynecology journal that delve into pelvic organ prolapse.

"Hopefully, this will be a resource for people who are preparing for birth, or who have recently experienced birth," says Linda Brubaker, MD, MS.

The FDA approval is supported by data from the phase 3 ALLIUM trial, which demonstrated the non-inferiority and superiority of cefepime/enmetazobactam vs piperacillin/tazobactam.

Postoperative urinary retention is a common outcome after surgical procedures for pelvic organ prolapse and stress urinary incontinence.